+152.7%
MPWR vs MRNA
-70.7%
+223.4%
-51.6%
Performance
Returns, benchmark comparison, and relative performance.
Performance by timeframe
Returns for 5y.
| Period | Portfolio | MRNA | Excess | Alpha |
|---|---|---|---|---|
| 1D | -1.2% | -3.4% | +2.2% | -0.9% |
| 7D | -1.3% | -10.1% | +8.8% | -0.3% |
| 30D | -12.8% | +126.7% | -139.6% | -28.0% |
| 3M | -21.3% | +184.1% | -205.4% | -40.3% |
| 6M | +13.7% | +143.3% | -129.5% | -10.5% |
| YTD | +33.3% | +359.9% | -326.6% | -13.9% |
| 1Y | +41.3% | +454.2% | -412.9% | -15.1% |
| 3Y | +145.8% | +26.0% | +119.8% | +104.5% |
| All | +152.7% | -70.7% | +223.4% | +161.7% |
Cumulative growth
Daily Returns
Daily percentage return beside MRNA.
Daily Out/Under-Performance
Portfolio return minus MRNA return. Positive bars indicate outperformance.
Daily Alpha
Portfolio daily return minus β × MRNA return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.
Cumulative Out/Under-Performance
Relative wealth over 5y: compounded portfolio wealth divided by compounded MRNA wealth, less one. Both series rebase at the selected span's start.
Cumulative Alpha
Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.
Updating return analytics…
5y analysis · Full analysis span regression · 6 months rolling